Publications by authors named "Elizabeth Cull"

Claim this Profile
F
Feasibility and Clinical Utility of Patient-Reported Outcome Measurement Information System-29 in a Newly Established Adolescent and Young Adult Oncology Program.
Patrick Smith, Benjamin Snyder, Maria McDaniel, Madeleine St Ville, Elizabeth Cull

J Adolesc Young Adult Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study.
Michael Maris, Gilles Salles, Won Seog Kim, Tae Min Kim, Roger M Lyons, Elizabeth Cull

Target Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma.
Ahmad S Halwani, Carlos Panizo, Iris Isufi, Alex F Herrera, Craig Y Okada, Elizabeth H Cull

Leuk Lymphoma· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural and Ultrastructural Analysis of the Multiple Myeloma Cell Niche and a Patient-Specific Model of Plasma Cell Dysfunction.
Katrina A Harmon, Sara Roman, Harrison D Lancaster, Saeeda Chowhury, Elizabeth Cull

Microsc Microanal· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMA.
Justin Watts, Tara L Lin, Alice Mims, Prapti Patel, Cynthia Lee, Elizabeth Cull

Front Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436.
Fatih M Uckun, Justin Watts, Alice S Mims, Prapti Patel, Eunice Wang, Elizabeth Cull

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers.
William Jeffery Edenfield, Ki Chung, Mark O'Rourke, Elizabeth Cull, Julie Martin

Oncologist· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome.
Fatih M Uckun, Tara L Lin, Alice S Mims, Prapti Patel, Cynthia Lee, Elizabeth Cull

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype.
Kelsie E Oatmen, Elizabeth Cull, Francis G Spinale

Nat Rev Cardiol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Politics trumps policy: How health ministers make decisions.
Elizabeth Cull

Healthc Manage Forum· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Use of Anti-Xa Monitoring in Malignancy-Associated Thrombosis.
Sarah Yentz, Oluwatoyosi A Onwuemene, Brady L Stein, Elizabeth H Cull, Brandon McMahon

Thrombosis· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia presenting with panhypopituitarism or diabetes insipidus: a case series with molecular genetic analysis and review of the literature.
Elizabeth H Cull, Justin M Watts, Martin S Tallman, Peter Kopp, Mark Frattini

Leuk Lymphoma· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary treatment of APL.
Elizabeth H Cull, Jessica K Altman

Curr Hematol Malig Rep· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The coagulopathy in acute promyelocytic leukaemia--what have we learned in the past twenty years.
Hau C Kwaan, Elizabeth H Cull

Best Pract Res Clin Haematol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death.
Jessica K Altman, Alfred Rademaker, Elizabeth Cull, Bing Bing Weitner, Yishai Ofran

Leuk Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenic infarction, warm autoimmune hemolytic anemia and antiphospholipid antibodies in a patient with infectious mononucleosis.
Elizabeth Cull, Brady L Stein

Int J Hematol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis